Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 16 studies | 25% ± 13% | |
| microglial cell | 13 studies | 62% ± 17% | |
| macrophage | 9 studies | 36% ± 16% | |
| myeloid cell | 7 studies | 24% ± 8% | |
| GABAergic neuron | 6 studies | 40% ± 20% | |
| interneuron | 6 studies | 42% ± 23% | |
| dendritic cell | 6 studies | 25% ± 7% | |
| glutamatergic neuron | 5 studies | 37% ± 22% | |
| capillary endothelial cell | 5 studies | 18% ± 3% | |
| non-classical monocyte | 5 studies | 22% ± 5% | |
| endothelial cell of lymphatic vessel | 5 studies | 21% ± 7% | |
| oligodendrocyte precursor cell | 4 studies | 23% ± 6% | |
| monocyte | 4 studies | 24% ± 8% | |
| mononuclear phagocyte | 3 studies | 29% ± 13% | |
| conventional dendritic cell | 3 studies | 18% ± 3% | |
| granule cell | 3 studies | 31% ± 9% | |
| type I pneumocyte | 3 studies | 20% ± 3% | |
| podocyte | 3 studies | 63% ± 12% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 9 studies | 35% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 98% | 499.42 | 2595 / 2642 | 96% | 3.25 | 675 / 705 |
| skin | 100% | 436.77 | 1808 / 1809 | 78% | 2.14 | 367 / 472 |
| esophagus | 98% | 152.66 | 1419 / 1445 | 77% | 1.41 | 140 / 183 |
| ovary | 100% | 219.35 | 180 / 180 | 59% | 1.12 | 254 / 430 |
| kidney | 100% | 264.02 | 89 / 89 | 51% | 1.05 | 458 / 901 |
| breast | 100% | 232.93 | 458 / 459 | 51% | 0.83 | 565 / 1118 |
| lung | 100% | 296.77 | 576 / 578 | 43% | 0.67 | 499 / 1155 |
| uterus | 100% | 203.82 | 170 / 170 | 42% | 0.73 | 194 / 459 |
| adrenal gland | 100% | 232.18 | 257 / 258 | 35% | 0.55 | 80 / 230 |
| bladder | 100% | 181.62 | 21 / 21 | 26% | 0.40 | 133 / 504 |
| thymus | 99% | 161.98 | 647 / 653 | 22% | 0.30 | 133 / 605 |
| intestine | 94% | 147.95 | 905 / 966 | 16% | 0.27 | 83 / 527 |
| prostate | 95% | 123.30 | 232 / 245 | 10% | 0.13 | 52 / 502 |
| spleen | 100% | 240.23 | 241 / 241 | 0% | 0 | 0 / 0 |
| stomach | 65% | 70.50 | 232 / 359 | 35% | 0.59 | 101 / 286 |
| blood vessel | 100% | 238.08 | 1332 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 100% | 316.51 | 1201 / 1204 | 0% | 0 | 0 / 0 |
| heart | 83% | 94.86 | 714 / 861 | 0% | 0 | 0 / 0 |
| pancreas | 39% | 29.17 | 128 / 328 | 40% | 0.60 | 72 / 178 |
| peripheral blood | 68% | 70.62 | 629 / 929 | 0% | 0 | 0 / 0 |
| liver | 36% | 24.93 | 81 / 226 | 9% | 0.13 | 36 / 406 |
| muscle | 34% | 24.48 | 277 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 31% | 0.46 | 14 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 14% | 0.15 | 4 / 29 |
| eye | 0% | 0 | 0 / 0 | 11% | 0.17 | 9 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0051963 | Biological process | regulation of synapse assembly |
| GO_0007399 | Biological process | nervous system development |
| GO_0098978 | Cellular component | glutamatergic synapse |
| Gene name | SRGAP2B |
| Protein name | SLIT-ROBO Rho GTPase activating protein 2B SLIT-ROBO Rho GTPase-activating protein 2B (SLIT-ROBO Rho GTPase activating protein 2 pseudogene 2) |
| Synonyms | SRGAP2P2 |
| Description | FUNCTION: May regulate cell migration and differentiation through interaction with and inhibition of SRGAP2 . In contrast to SRGAP2C, it is not able to induce long-lasting changes in synaptic density throughout adulthood . . |
| Accessions | A0A087WW56 A0A087X1G6 ENST00000641863.3 ENST00000612199.4 P0DMP2 ENST00000619678.2 A0A286YEY3 ENST00000621582.1 |